Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Dec 08, 2020 10:47am
174 Views
Post# 32057491

RE:RE:Trading time left in December/2020

RE:RE:Trading time left in December/2020,,Oww,,yepper,,agreed there GV,,,,,it just puts a sour taste in ones mouth everytime we see such a lack of interest in something that is touted by our supreme leader as being of incredible value.....not sure who is fooling who here....These low price levels must be viewed as favoring only accredited investors and insiders and not the average retail investor. Why haven't a few of the big funds taken a position when the BTD was issued from the FDA?....that is something that speaks directly to lack of credibility imo,,,,,,the market is seldom wrong,,,,we sit back and must view this investment as a personal gambling addition at this point,,,nothing less and nothing more,,when it should be far from such,,,,,!
<< Previous
Bullboard Posts
Next >>